INMB
Inmune Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
+6.88%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+57.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | SAPIRSTEIN JAMES · director | A-Award | 100,000 | $2.33 |
| Jul 7, 2026 | Moss David J · director, officer: Chief Executive Officer | M-Exempt | 9,014 | $1.40 |
| Jul 7, 2026 | Lowdell Mark William · officer: Chief Scientific Officer | M-Exempt | 7,211 | $1.40 |
| Jul 7, 2026 | Juda Scott · director | M-Exempt | 14,801 | $1.40 |
| Dec 2, 2025 | Ganjei James Kelly · director | A-Award | 150,000 | $1.48 |
| Dec 2, 2025 | ALLEN MARCIA · director | A-Award | 150,000 | $1.48 |
| Dec 2, 2025 | Lowdell Mark William · officer: Chief Scientific Officer | A-Award | 600,000 | $1.48 |
| Dec 2, 2025 | Moss David J · director, officer: Chief Executive Officer | A-Award | 750,000 | $1.48 |
| Dec 2, 2025 | Ellspermann Cory Randall · officer: CFO | A-Award | 300,000 | $1.48 |
| Dec 2, 2025 | Schroeder Timothy j · director | A-Award | 150,000 | $1.48 |
| Dec 2, 2025 | Juda Scott · director | A-Award | 150,000 | $1.48 |
| Nov 18, 2025 | Moss David J · director, officer: Chief Executive Officer | A-Award | 130,000 | $1.50 |
| Nov 18, 2025 | Moss David J · director, officer: Chief Executive Officer | A-Award | 70,663 | $1.50 |
| Nov 18, 2025 | Moss David J · director, officer: Chief Executive Officer | A-Award | 59,337 | $1.50 |
| Nov 18, 2025 | Lowdell Mark William · officer: Chief Scientific Officer | A-Award | 400,000 | $1.50 |
| Nov 18, 2025 | Lowdell Mark William · officer: Chief Scientific Officer | A-Award | 180,000 | $1.50 |
| Nov 18, 2025 | Lowdell Mark William · officer: Chief Scientific Officer | A-Award | 104,000 | $1.50 |
| Nov 18, 2025 | Lowdell Mark William · officer: Chief Scientific Officer | A-Award | 100,000 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 108,000 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 35,000 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 32,500 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 19,025 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 15,975 | $1.50 |
| Nov 18, 2025 | Juda Scott · director | A-Award | 12,500 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 108,000 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 35,000 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 32,500 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 19,025 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 15,975 | $1.50 |
| Nov 18, 2025 | Ganjei James Kelly · director | A-Award | 12,500 | $1.50 |
Institutional positioning
13F filings over the trailing two quarters
New 41Increased 53Reduced 45Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 1,194,112 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 706,424 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 687,015 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 662,218 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 494,969 | May 15, 2026 |
| BlackRock, Inc. | Reduced | 311,613 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 290,879 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 270,317 | May 15, 2026 |
| UBS GROUP AG | Increased | 253,340 | May 5, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 243,191 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 240,252 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 231,586 | May 15, 2026 |
| RAYMOND JAMES FINANCIAL INC | Increased | 212,995 | Aug 14, 2026 |
| RAYMOND JAMES FINANCIAL INC | Reduced | 203,245 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 190,215 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 17, 2026